LPL Financial
RCUS icon

LPL Financial’s Arcus Biosciences RCUS Stock Holding History

LPL Financial’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$692K Sell
22,449
-411
-2% -$10.2K ﹤0.01% 4753
2026
Q1 		$494K Sell
22,860
-1,351
-6% -$29.2K ﹤0.01% 4762
2025
Q4 		$577K Buy
24,211
+1,302
+6% +$26.6K ﹤0.01% 4590
2025
Q3 		$312K Buy
22,909
+355
+2% +$3.69K ﹤0.01% 5023
2025
Q2 		$184K Buy
22,554
+4,120
+22% +$35.2K ﹤0.01% 5119
2025
Q1 		$145K Buy
18,434
+4,900
+36% +$56.8K ﹤0.01% 4952
2024
Q4 		$202K Buy
13,534
+175
+1% +$2.86K ﹤0.01% 4814
2024
Q3 		$204K Buy
13,359
+161
+1% +$2.54K ﹤0.01% 4714
2024
Q2 		$201K Buy
13,198
+3,135
+31% +$50.6K ﹤0.01% 4571
2024
Q1 		$190K Buy
+10,063
New +$174K ﹤0.01% 4521

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

LPL Financial's RCUS Position: Q2 2026 in Review

LPL Financial reduced its Arcus Biosciences (RCUS) stake by 1.8% in Q2 2026, selling an estimated $10.2K and leaving 22,449 shares worth $692K. The position accounts for ﹤0.01% of the portfolio, ranked #4753.

LPL Financial first reported a position in RCUS in Q1 2024 and has held it in 10 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • LPL Financial held 22,449 shares of Arcus Biosciences worth $692K as of Q2 2026.
  • LPL Financial sold 411 Arcus Biosciences shares in Q2 2026, an estimated $10.2K.
  • Arcus Biosciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4753 holding.
  • LPL Financial first reported a position in Arcus Biosciences in Q1 2024 and has held it in 10 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.